Table 2. Patient characteristics.
Characteristics | Number of patients | % |
---|---|---|
Age (years) | ||
Median | 59 | |
Range | 51–74 | |
Gender | ||
Male | 9 | 43 |
Female | 12 | 57 |
Karnofsky performance status | ||
100 | 12 | 57 |
90 | 8 | 38 |
80 | 1 | 5 |
Tumour location | ||
Head | 13 | 62 |
Body-tail | 8 | 38 |
Maximum tumour size (mm) | ||
Median | 37 | |
Range | 25–60 | |
CEA (ng/ml) | ||
Median | 4.5 | |
Range | 1.0–75.0 | |
CA19-9 (U/ml) | ||
Median | 759 | |
Range | 1–6,300 |
CEA=carcinoembryonic antigen; CA19–9=carbohydrate antigen 19–9.